Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Not All Infectious Microorganisms Malign Human Immune System

Simon M. Helfgott, MD  |  Issue: November 2016  |  November 16, 2016

The discovery of the pivotal role of the human microbiome has challenged some of the long-held anachronistic views that considered all infectious agents to be evildoers.

The discovery of the pivotal role of the human microbiome has challenged some of the long-held anachronistic views that considered all infectious agents to be evildoers.
Kateryna Kon/shutterstock.com

Which came first? The infectious microorganism or a host’s immune resistance against it?

Through the millennia, a raging battle has pitted the hordes of infectious agents surrounding us against, arguably, the most complex biologic structure ever created, the finely tuned human immune system. The stakes are high for both sides. For the infectious agent, an inability to penetrate the host defenses may lead to its imminent demise and an untimely death. For the host, letting its guard down can lead to some dire consequences including infection, illness or, if molecular mimicry holds true, the development of autoimmunity.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Yet life on our planet as we know it would cease without the presence of these pesky bugs. In fact, the discovery of the pivotal role of the human microbiome has challenged some of the long-held anachronistic views that considered all infectious agents to be evildoers. It may be hard to conceptualize that lurking within each and every one of us resides a population of well over 100 trillion bacteria, or 10-fold the number of cells in our bodies, that is estimated to weigh 5 lbs.1 These massive colonies of bacteria and their infinite generations of progeny have taken up lifelong residence within our gut, oral cavities, skin, lungs, eyes and elsewhere. Till death do us part.

What are they doing within? Some, if not most of these organisms bear no malice and contribute to our host defenses in most meaningful ways. For example, we are discovering their pivotal role in the pathogenesis of cancer, rheumatoid arthritis, inflammatory bowel disease and a host of other autoimmune diseases.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In a similar vein, the human virome, the virtual home for all viral vectors lurking within, exerts its own profound influence on our lives in times of health and disease. Given the nanoscale size of viruses and their infectious snippets of DNA and RNA, it should come as no surprise to learn that the number of free virions just residing at body barrier sites, such as the gut, oropharynx and skin, may range as high as 109 particles per gram. Step aside, microbiome: It has been estimated that the human body may contain an eye-popping 1015 bacteriophages that regulate the structure and function of bacterial communities through their lytic and lysogenic cycles.3 Don’t forget to pass the hand sanitizer.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:autoimmunityDiseaseessential mixed cryoglobulinemiaHepatitis C virushuman microbiomeImmune SystemInfectionmicroorganism

Related Articles
    Dr. Kawasaki

    Tomisaku Kawasaki, Pediatrician Who Discovered Disease That Bears His Name, Dies at 95

    June 18, 2020

    Japanese pediatrician Tomisaku Kawasaki, MD, who identified an inflammatory syndrome that affects children, died on June 5 in Tokyo. He was 95. Tenacity & Attention to Detail Born Feb. 7, 1925, in Tokyo, Dr. Kawasaki graduated from medical school at what is now Chiba University in Chiba, Japan, in 1948 and worked as staff pediatrician…

    MIA Studio / shutterstock.com

    Kawasaki Guideline Urges Treatment Intensification for Some Patients

    December 16, 2021

    A soon-to-be published guideline from the ACR and the Vasculitis Foundation on Kawasaki disease underscores the importance of early diagnosis and intensified treatment for people with this serious condition.1 Intravenous immunoglobulin (IVIG) remains the treatment mainstay, and prompt, aggressive treatment may be able to reduce the risk of serious complications in some patients. The guideline…

    The Microbiome

    November 1, 2011

    A voyage to (our inner) Lilliput

    Thinking Big, Thinking Small

    June 17, 2019

    I would like to tell you a story. Two, actually. I am just returning from the 19th International Vasculitis and ANCA Workshop, which is always a fascinating meeting. In its inception, it was a workshop, in the true sense of the word. Now, we discuss anti-neutrophil cytoplasmic antibody (ANCA) testing as casually as we discuss…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences